Skip to main content

Table 4 Clinical results

From: Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis

Endpoints

30 days

12 Mo

n = 204 (%)

n = 204 (%)

MACE

7 (3.4)a

14 (6.9)

Death

0

0

cardiac death

0

0

MI

7 (3.4)a

3 (1.5)

Stroke

0

1 (0.5)

ST

0

0

TLR

0

11 (5.4)

TVR

0

15 (7.4)

PCI in another vessel

8 (3.9)

19 (9.3)

  1. MACE major adverse cardiovascular event, MI myocardial infarction, PCI percutaneous coronary intervention, ST stent thrombosis, TLR target lesion revascularization, TVR target vessel revascularization
  2. aperiprocedural MI type 4a